Treatment of Proximal Renal Tubular Acidosis in Fanconi Syndrome
Clinical Scenario
This protocol addresses proximal renal tubular acidosis occurring in the context of
Fanconi syndrome — a condition characterised by
widespread proximal tubular dysfunction. Beyond impaired bicarbonate reabsorption,
Fanconi syndrome involves loss of phosphate, glucose, uric acid, amino acids, and
low-molecular-weight proteins, making management more complex than isolated proximal RTA.
Treatment Approach
Management in this setting typically involves alkali therapy, along with measures to
address the broader consequences of proximal tubular dysfunction — including volume status
and bone health.
The complete regimen — including agents, sequencing, and supplementation targets — is in the full protocol below.
References
-
Proximal RTA may occur as an isolated defect in HCO3– reabsorption, but more typically occurs in association with Fanconi syndrome, characterized by a widespread proximal tubular dysfunction resulting in the loss of phosphate, glucose, uric acid, amino acids, and low molecular weight proteins, as well as HCO3–.
-
In contrast, treatment of proximal RTA is often challenging and patients require larger quantities of alkali therapy, which are usually administered as a K+ salt (e.g., K-citrate) to avoid worsening hypokalemia.
-
In addition to alkali therapy, patients with Fanconi syndrome are treated with fluid and electrolyte replacement to prevent volume depletion, as well as supplementation with vitamin D and phosphate to prevent bone disease.
DOI: 10.6084/m9.figshare.13286027
View source ↗